化学
细胞生物学
磷酸化
免疫沉淀
骨质疏松症
信使核糖核酸
核糖核酸
癌症研究
内分泌学
内科学
生物
医学
生物化学
基因
作者
Fei Zhang,C. Liu,Zhiyong Chen,Chengyi Zhao
摘要
Abstract Osteoporosis is a chronic skeletal disease and the major source of risk for fractures in aged people. It is urgent to investigate the mechanism regulating osteoporosis for developing potential treatment and prevention strategies. Osteogenic differentiation of preosteoblast enhances bone formation, which might be a promising strategy for treatment and prevention of osteoporosis. Protein disulfide isomerase family A, member 3 (PDIA3) could induce bone formation, yet the role of PDIA3 in osteogenic differentiation of preosteoblast remains unknown. In this study, m 6 A RNA methylation was detected by methylated RNA immunoprecipitation (MeRIP), while mRNA stability was identified by RNA decay assay. Besides, protein−protein interaction and protein phosphorylation were determined using co‐immunoprecipitation (Co‐IP). Herein, results revealed that PDIA3 promoted osteogenic differentiation of preosteoblast MC3T3‐E1. Besides, PDIA3 mRNA methylation was suppressed by FTO alpha‐ketoglutarate dependent dioxygenase (FTO) as RNA methylation reduced PDIA3 mRNA stability during osteogenic differentiation of MC3T3‐E1 cells. Moreover, ubiquitin specific peptidase 20 (USP20) improved FTO level through inhibiting FTO degradation while PDIA3 increased FTO level by enhancing USP20 phosphorylation during osteogenic differentiation of MC3T3‐E1 cells, suggesting a positive feedback regulatory loop between PDIA3 and FTO. In summary, these findings indicated the mechanism of PDIA3 regulating osteogenic differentiation of preosteoblast and provided potential therapeutic targets for osteoporosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI